Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.business-standard.com/markets/capital-market-news/marksans-pharma-declines-after-us-fda-issues-form-483-with-5-observations-to-goan-plant-124041800302_1.html
https://www.indianpharmapost.com/news/marksans-q3-fy24-revenue-up-22-at-rs-586-cr-15275
https://www.indianpharmapost.com/news/marksans-receives-usfda-approval-for-guaifenesin-extended-release-tablets-14565
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217780
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216994
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/marksans-pharma-gets-final-usfda-nod-for-generic-version-of-famotidine-tablets/articleshow/98538255.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217543
https://www.indianpharmapost.com/news/marksans-pharma-announces-uk-mhra-approval-for-fluoxetine-20mg5ml-oral-solution-13640
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/marksans-pharma-acquires-tevas-manufacturing-site-in-goa/articleshow/94789435.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.expresspharma.in/marksans-acquires-capacity-from-tevapharm-india/